The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-γ

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 284-290

  Grela, Françoise ^a   Aumeunier, Aude ^a,c   Bardel, Emilie ^a   Van, Linh Pham ^a   Bourgeois, Elvire ^a,d   Vanoirbeek, Jeroen ^b   Leite de Moraes, Maria ^a   Schneider, Elke ^a   Dy, Michel ^a   Herbelin, André ^a,c,d   Thieblemont, Nathalie ^a  

^a CNRS   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12; RESIQUIMOD; TOLL LIKE RECEPTOR 7;

ADOPTIVE TRANSFER; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG RECEPTOR BINDING; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION; WILD TYPE;

EID: 79251554653     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001348     Document Type: Article

References (33)

1. Strachan, D. P. 1989. Hay fever, hygiene, and household size. BMJ 299: 1259-1260.
2. Kalliomäki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
3. Shirakawa, T., T. Enomoto, S. Shimazu, and J. M. Hopkin. 1997. The inverse association between tuberculin responses and atopic disorder. Science 275: 77-79.
4. Jurk, M., F. Heil, J. Vollmer, C. Schetter, A. M. Krieg, H. Wagner, G. Lipford, and S. Bauer. 2002. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3: 499.
5. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303: 1526-1529.
6. Camateros, P., M. Tamaoka, M. Hassan, R. Marino, J. Moisan, D. Marion, M. C. Guiot, J. G. Martin, and D. Radzioch. 2007. Chronic asthma-induced airway remodeling is prevented by Toll-like receptor-7/8 ligand S28463. Am. J. Respir. Crit. Care Med. 175: 1241-1249.
7. Sel, S., M. Wegmann, S. Sel, S. Bauer, H. Garn, G. Alber, and H. Renz. 2007. Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J. Immunol. 178: 7805-7813.
8. Xirakia, C., O. Koltsida, A. Stavropoulos, A. Thanassopoulou, V. Aidinis, P. Sideras, and E. Andreakos. 2010. TLR7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am. J. Respir. Crit Care Med. 181: 1207-1216.
9. Camateros, P., C. Kanagaratham, J. Henri, R. Sladek, T. J. Hudson, and D. Radzioch. 2009. Modulation of the allergic asthma transcriptome following resiquimod treatment. Physiol. Genomics 38: 303-318.
10. Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L. M. Araujo, P. Hachem, J. M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171: 1637-1641.
11. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
12. Matsuda, H., T. Suda, J. Sato, T. Nagata, Y. Koide, K. Chida, and H. Nakamura. 2005. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33: 22-31.
13. Hachem, P., M. Lisbonne, M. L. Michel, S. Diem, S. Roongapinun, J. Lefort, G. Marchal, A. Herbelin, P. W. Askenase, M. Dy, and M. C. Leite-de-Moraes. 2005. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur. J. Immunol. 35: 2793-2802.
14. Morishima, Y., Y. Ishii, T. Kimura, A. Shibuya, K. Shibuya, A. E. Hegab, T. Iizuka, T. Kiwamoto, Y. Matsuno, T. Sakamoto, et al. 2005. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur. J. Immunol. 35: 2803-2814.
15. Michel, M. L., A. C. Keller, C. Paget, M. Fujio, F. Trottein, P. B. Savage, C. H. Wong, E. Schneider, M. Dy, and M. C. Leite-de-Moraes. 2007. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204: 995-1001.
16. Aumeunier, A., F. Grela, A. Ramadan, L. Pham Van, E. Bardel, A. Gomez Alcala, P. Jeannin, S. Akira, J. F. Bach, and N. Thieblemont. 2010. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 5: e11484.
17. Leite-De-Moraes, M. C., G. Moreau, A. Arnould, F. Machavoine, C. Garcia, M. Papiernik, and M. Dy. 1998. IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12: influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 28: 1507-1515.
18. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
19. Nagarajan, N. A., and M. Kronenberg. 2007. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178: 2706-2713. (Pubitemid 46335652)
20. Tyznik, A. J., E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg. 2008. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181: 4452-4456.
21. Bourgeois, E., L. P. Van, M. Samson, S. Diem, A. Barra, S. Roga, J. M. Gombert, E. Schneider, M. Dy, P. Gourdy, et al. 2009. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 39: 1046-1055.
22. Meyer, E. H., S. Goya, O. Akbari, G. J. Berry, P. B. Savage, M. Kronenberg, T. Nakayama, R. H. DeKruyff, and D. T. Umetsu. 2006. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA 103: 2782-2787.
23. Brugnolo, F., S. Sampognaro, F. Liotta, L. Cosmi, F. Annunziato, C. Manuelli, P. Campi, E. Maggi, S. Romagnani, and P. Parronchi. 2003. The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. J. Allergy Clin. Immunol. 111: 380-388.
24. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8: 625-629.
25. Stock, P., T. Kallinich, O. Akbari, D. Quarcoo, K. Gerhold, U. Wahn, D. T. Umetsu, and E. Hamelmann. 2004. CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur. J. Immunol. 34: 1817-1827.
26. Lagranderie, M., M. Abolhassani, J. A. Vanoirbeek, C. Lima, A. M. Balazuc, B. B. Vargaftig, and G. Marchal. 2010. Mycobacterium bovis bacillus Calmette-Guérin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. J. Immunol. 184: 1062-1070.
27. Paget, C., T. Mallevaey, A. O. Speak, D. Torres, J. Fontaine, K. C. Sheehan, M. Capron, B. Ryffel, C. Faveeuw, M. Leite de Moraes, et al. 2007. Activation of invariant NKT cells by Toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
28. Paget, C., E. Bialecki, J. Fontaine, C. Vendeville, T. Mallevaey, C. Faveeuw, and F. Trottein. 2009. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J. Immunol. 182: 1846-1853.
29. Van Dommelen, S. L., and M. A. Degli-Esposti. 2004. NKT cells and viral immunity. Immunol. Cell Biol. 82: 332-341.
30. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921-930.
31. Grubor-Bauk, B., A. Simmons, G. Mayrhofer, and P. G. Speck. 2003. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Valpha 14-J alpha 281 TCR. J. Immunol. 170: 1430-1434.
32. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77: 10168-10171.
33. Wesley, J. D., M. S. Tessmer, D. Chaukos, and L. Brossay. 2008. NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog. 4: e1000106.